Selected article for: "acute respiratory and admission critical"
Author: Bowman, Emily R; Cameron, Cheryl M Ainslie; Avery, Ann; Gabriel, Janelle; Kettelhut, Aaren; Hecker, Michelle; Ute Sontich, Claudia; Tamilselvan, Banumathi; Nichols, Carmen N; Richardson, Brian; Cartwright, Michael; Funderburg, Nicholas T; Cameron, Mark J
Title: Levels of Soluble CD14 and Tumor Necrosis Factor Receptors 1 and 2 may be predictive of death in Severe Coronavirus Disease 2019 (COVID-19)
  • Cord-id: tlxeo7d6
  • Document date: 2020_11_29
    • ID: tlxeo7d6
    Snippet: People infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) display a wide range of illness, from asymptomatic infection to severe respiratory distress resulting in death. We measured serum biomarkers in uninfected individuals and in individuals with mild, moderate, or critical COVID-19 disease. Levels of monocyte activation (sCD14 and FABP4) and inflammation (TNFR1 and 2) were increased in COVID-19 individuals, regardless of disease severity. Among patients with critic
    Document: People infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) display a wide range of illness, from asymptomatic infection to severe respiratory distress resulting in death. We measured serum biomarkers in uninfected individuals and in individuals with mild, moderate, or critical COVID-19 disease. Levels of monocyte activation (sCD14 and FABP4) and inflammation (TNFR1 and 2) were increased in COVID-19 individuals, regardless of disease severity. Among patients with critical disease, individuals who recovered from COVID-19 had lower levels of TNFR1 and TNFR2 at hospital admission compared to these levels in patients with critical disease that ultimately died.

    Search related documents:
    Co phrase search for related documents
    • activation marker and low density: 1
    • activation marker and lymphocyte activation: 1, 2
    • acute respiratory syndrome and longitudinal sectional: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute respiratory syndrome and longitudinal sectional study: 1, 2, 3, 4, 5
    • acute respiratory syndrome and low density: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and low density lipoprotein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory syndrome and lymphocyte activation: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome and macrophage monocyte: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and macrophage monocyte activation: 1, 2, 3, 4, 5, 6, 7, 8
    • low density and macrophage monocyte: 1, 2
    • low density lipoprotein and macrophage monocyte: 1, 2
    • lymphocyte activation and macrophage monocyte: 1, 2
    • lymphocyte activation and macrophage monocyte activation: 1, 2